The Kiteworks research reveals that 27% of life organizations acknowledge that more than 30% of their AI-processed data contains sensitive or private information. In pharmaceutical contexts, this ...

ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc ...

In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...

Most pharma companies struggle to scale generative AI beyond pilot projects owing to infrastructure and data ...

The pharmaceutical supply chain, vital for the continuous flow of life-saving drugs and treatments, has historically been vulnerable to external shocks and internal inefficiencies. The study reveals ...

Learn how data brokers and AI harvest your digital life. Learn to protect your personal data privacy from invisible tracking ...

From clinical trials to commercialization, pharma organizations are under immense pressure to reduce time to market.

A novel approach from the Allen Institute for AI enables data to be removed from an artificial intelligence model even after ...

Scientist.com, the leading R&D procurement orchestration platform for the life sciences, today announced a major expansion of its Tumor Model Finder (TMF) following a strategic partnership with ...

Our approach is to create a strawman schematic of the required model design based on the disease and therapeutic structure, along with a future event audit. Then, map this against the available data.

In the high-stakes world of pharmaceutical compliance, where billions of dollars and regulatory scrutiny intersect, ...

ORLANDO, FLORIDA / ACCESS Newswire / July 18, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and BullFrog AI, Inc. (Nasdaq:BFRG) on the RedChip Small St ...